Investigating Coating Adhesion Failures in Enteric-Coated Tablets During Testing

Investigating Coating Adhesion Failures in Enteric-Coated Tablets During Testing

Published on 29/12/2025

Investigating Coating Adhesion Failures in Enteric-Coated Tablets During Testing

Introduction:

Enteric-coated tablets are designed to withstand the acidic environment of the stomach and dissolve in the more neutral environment of the intestines. This targeted drug delivery system is crucial for drugs that are sensitive to stomach acid or are intended to act in the intestines. However, coating adhesion failures during testing can compromise the tablet’s effectiveness and safety. Investigating these failures is essential to ensure the tablets meet quality standards and regulatory requirements.

Challenges and Issues:

  • Inadequate adhesion of the enteric coating, leading to premature dissolution in the stomach.
  • Cracking or peeling of the coating during handling and testing.
  • Variability in coating thickness, affecting dissolution rates.
  • Incompatibility between the core tablet and coating materials.
  • Environmental factors such as humidity affecting coating stability.
Pharma Tip:  Ensuring Proper Coding and Serialization in High-Speed Packaging Lines

Step-by-Step Troubleshooting Guide:

  1. Material Selection: Evaluate the compatibility of the enteric coating polymers with the core tablet. Ensure that the chosen materials have appropriate mechanical and chemical properties to withstand manufacturing and testing processes.
  2. Coating Process Optimization: Fine-tune the coating process parameters such as spray rate, inlet air temperature, and drying time. Consistent process control can reduce variability in coating thickness and adhesion.
  3. Environmental Control: Maintain optimal humidity and temperature
conditions during the coating process. Environmental controls are critical to prevent coating defects such as cracking or peeling.
  • Testing and Monitoring: Implement rigorous in-process testing to monitor coating adhesion. Use techniques such as tensile testing or peel testing to assess the mechanical strength of the coating.
  • Quality Assurance Protocols: Develop robust quality assurance protocols to identify and rectify coating failures early in the production process. This includes regular equipment calibration and maintenance.
  • Batch-to-Batch Consistency: Ensure consistency in raw material quality and process parameters across batches to avoid variability in coating performance.

    • Regulatory Guidelines:

    Adhering to regulatory guidelines is crucial in the pharmaceutical industry. The USFDA provides comprehensive guidelines on the manufacture and testing of enteric-coated tablets. These include recommendations on coating materials, process validation, and quality control measures. Understanding and applying these guidelines ensure that the products meet safety and efficacy standards.

    Conclusion:

    Identifying and addressing coating adhesion failures in enteric-coated tablets is key to ensuring their performance and safety. By understanding the challenges and implementing a structured troubleshooting approach, pharmaceutical professionals can enhance coating adhesion and tablet quality. Adhering to regulatory guidelines further ensures compliance and supports the development of effective drug delivery systems. Investing in quality control and continuous improvement processes will yield long-term benefits in product reliability and patient satisfaction.

    Pharma Tip:  Ensuring Compliance with GMP Standards in Tablet Production

    Also Read